Afatinib alone or afatinib plus vinorelbine versus...

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial

Cortés, Javier, Dieras, Véronique, Ro, Jungsil, Barriere, Jérôme, Bachelot, Thomas, Hurvitz, Sara, Le Rhun, Emilie, Espié, Marc, Kim, Sung-Bae, Schneeweiss, Andreas, Sohn, Joo Hyuk, Nabholtz, Jean-Mar
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00373-3
Date:
December, 2015
File:
PDF, 384 KB
english, 2015
Conversion to is in progress
Conversion to is failed